NCT00157911View on ClinicalTrials.gov

A Study to Evaluate Ezetimibe in Korean Patients With Primary Hypercholesterolemia (0653-042)

PHASE3CompletedINTERVENTIONAL
Enrollment

136

Participants

Timeline

Start Date

December 31, 2002

Primary Completion Date

October 31, 2003

Study Completion Date

December 31, 2003

Conditions
Hypercholerolemia
Interventions
DRUG

MK0653; ezetimibe / Duration of Treatment: 12 weeks

DRUG

Comparator: simvastatin / Duration of Treatment: 12 weeks

All Listed Sponsors
lead

Organon and Co

INDUSTRY

NCT00157911 - A Study to Evaluate Ezetimibe in Korean Patients With Primary Hypercholesterolemia (0653-042) | Biotech Hunter | Biotech Hunter